Sissetulev kiriAvalik
Euroopa farmakopöa asjus
Ravimiamet · 28. veebruar 2025
- Viit
- REP-1/1045-1
- Registreeritud
- 28. veebruar 2025
- Dokumendi liik
- Sissetulev kiri
- Adressaat
- European Directorate for the Quality of Medicines & HealthCare
- Saabumis/saatmisviis
- e-post
- Funktsioon
- REP Euroopa Farmakopöaga seotud asjaajamine
- Sari
- REP-1 Euroopa Farmakopöa alane kirjavahetus
- Toimik
- REP-1/2025
- Vastutaja
- Signe Leito (RA, Peadirektori asetäitja valdkond, Labor)
Sisu (failidest)
Signe Leito
Saatja: [email protected]
Saatmisaeg: kolmapäev, 26. veebruar 2025 09:52
Adressaat: Signe Leito
Teema: Proposed suppression of the monograph on Ouabain 0048 from the Ph. Eur.: EDQM-2025-00946-mail
Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada.
Please make sure to include in any reply our mail reference: EDQM-2025-00946-mail
****************************************************************************
European Pharmacopoeia Commission Secretariat
RZ/PH/ 2025-00943L
Aba/mk
Strasbourg, 25 February 2025
LETTER FOR THE ATTENTION OF THE NPAs
Copy: Presidium
Dear Colleagues,
Please find below the link to a survey being carried out concerning the proposed suppression of the monograph on Ouabain (0048) from the work
programme of group of experts 11.
Please copy and paste this link into your Internet browser:
https://survey.edqm.eu/index.php?r=survey/index&sid=685725&lang=en
Deadline for replies: 13 March 2025
1
Kind regards,
On behalf of Aurélie BARTH
Mireille Kopf
Secretarial Assistant
European Pharmacopoeia Department
EDQM - Council of Europe
Tel.: +33 (0)3 88 41 28 53 / Fax: +33 (0)3 88 41 27 71
https://www.edqm.eu / https://store.edqm.eu
Stay connected with the EDQM
****************************************************************************
Please make sure to include in any reply our mail reference: EDQM-2025-00946-mail
2